Jake Allred

589 total citations
13 papers, 373 citations indexed

About

Jake Allred is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Jake Allred has authored 13 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Hematology. Recurrent topics in Jake Allred's work include Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (5 papers) and Cancer therapeutics and mechanisms (2 papers). Jake Allred is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Cancer Treatment and Pharmacology (5 papers) and Cancer therapeutics and mechanisms (2 papers). Jake Allred collaborates with scholars based in United States. Jake Allred's co-authors include Angela Dispenzieri, John Camoriano, Jamés O. Armitage, Dennis D. Weisenburger, Ahmet Doǧan, Susan M. Geyer, Kay M. Ristow, David M. Menke, Thomas M. Habermann and Edith A. Perez and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Jake Allred

13 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jake Allred United States	8	258	83	62	57	57	13	373
Olga L. Bohn United States	11	141 0.5×	65 0.8×	59 1.0×	81 1.4×	59 1.0×	18	352
Barbara Burroni France	9	224 0.9×	107 1.3×	77 1.2×	109 1.9×	16 0.3×	37	447
Remi Sumiyoshi Japan	11	99 0.4×	54 0.7×	49 0.8×	49 0.9×	140 2.5×	50	359
G. S. Nowakowski United States	6	203 0.8×	160 1.9×	91 1.5×	100 1.8×	9 0.2×	9	429
Laetitia Coutte France	5	268 1.0×	48 0.6×	31 0.5×	53 0.9×	58 1.0×	10	386
Monica Onorati Italy	9	138 0.5×	119 1.4×	16 0.3×	44 0.8×	23 0.4×	36	324
Junyan Qian China	12	123 0.5×	73 0.9×	28 0.5×	105 1.8×	90 1.6×	40	418
R. Mondéjar Spain	8	219 0.8×	27 0.3×	13 0.2×	67 1.2×	38 0.7×	23	380
Kyotaro Ohno Japan	13	122 0.5×	65 0.8×	56 0.9×	14 0.2×	319 5.6×	23	519
Atsushi Isoda Japan	10	158 0.6×	139 1.7×	19 0.3×	18 0.3×	21 0.4×	27	321

Countries citing papers authored by Jake Allred

Since Specialization

Citations

This map shows the geographic impact of Jake Allred's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jake Allred with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jake Allred more than expected).

Fields of papers citing papers by Jake Allred

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jake Allred. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jake Allred. The network helps show where Jake Allred may publish in the future.

Co-authorship network of co-authors of Jake Allred

This figure shows the co-authorship network connecting the top 25 collaborators of Jake Allred. A scholar is included among the top collaborators of Jake Allred based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jake Allred. Jake Allred is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Hopkins, Judith O., Jake Allred, Arti Hurria, et al.. (2017). Lymphedema, musculoskeletal events and arm function in older patients receiving adjuvant chemotherapy for breast cancer (Alliance A171302). Breast Cancer Research and Treatment. 166(3). 793–808. 9 indexed citations

Misra, Sanjay, et al.. (2016). Mortality and Renal Replacement Therapy after Renal Artery Stent Placement for Atherosclerotic Renovascular Disease. Journal of Vascular and Interventional Radiology. 27(8). 1215–1224. 14 indexed citations

Jatoi, Aminah, Hyman B. Muss, Jake Allred, et al.. (2015). Social support and its implications in older, early‐stage breast cancer patients in CALGB 49907 (Alliance A171301). Psycho-Oncology. 25(4). 441–446. 17 indexed citations

Dispenzieri, Angela, Jamés O. Armitage, Susan M. Geyer, et al.. (2012). The clinical spectrum of Castleman's disease. American Journal of Hematology. 87(11). 997–1002. 161 indexed citations

Reinholz, Monica M., Kathleen Tenner, David W. Hillman, et al.. (2011). Cytokeratin-19 and Mammaglobin Gene Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients Enrolled in North Central Cancer Treatment Group Trials, N0234/336/436/437. Clinical Cancer Research. 17(22). 7183–7193. 45 indexed citations

Lacy, M. Q., M. A. Gertz, S. R. Hayman, et al.. (2010). Activity of pomalidomide plus dexamethasone (Pom/dex) in dual lenalidomide/bortezomib refractory multiple myeloma (MM).. Journal of Clinical Oncology. 28(15_suppl). 8002–8002. 3 indexed citations

Mansfield, Aaron S., Shernan G. Holtan, Travis E. Grotz, et al.. (2010). Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis. Modern Pathology. 24(4). 487–494. 45 indexed citations

Dispenzieri, Angela, Gregory A. Wiseman, Martha Q. Lacy, et al.. (2010). A Phase II study of ¹⁵³Sm‐EDTMP and high‐dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma. American Journal of Hematology. 85(6). 409–413. 14 indexed citations

Dispenzieri, Angela, M. A. Gertz, S. R. Hayman, et al.. (2010). A phase II study of pomalidomide and dexamethasone in previously treated light-chain (AL) amyloidosis.. Journal of Clinical Oncology. 28(15_suppl). 8025–8025. 3 indexed citations

10.

Northfelt, Donald W., Jake Allred, Timothy J. Hobday, et al.. (2008). Phase II trial of paclitaxel polyglumex (PPX) with capecitabine (C) for metastatic breast cancer (MBC). Journal of Clinical Oncology. 26(15_suppl). 1063–1063. 2 indexed citations

11.

Roy, Vivek, et al.. (2008). N0338 phase II trial of docetaxel and carboplatin administered every two weeks as induction therapy for stage II or III breast cancer. Journal of Clinical Oncology. 26(15_suppl). 563–563. 52 indexed citations

12.

Dispenzieri, Angela, Martha Q. Lacy, Stephen R. Zeldenrust, et al.. (2008). Long Term Follow-up of Patients with Immunoglobulin Light Chain Amyloidosis Treated with Lenalidomide and Dexamethasone.. Blood. 112(11). 1737–1737. 6 indexed citations

13.

Roy, Vivek, A. Keith Stewart, P. Leif Bergsagel, et al.. (2008). Phase II Study of Melphalan, Prednisone and Lenalidomide Combination for Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplantation. Blood. 112(11). 2769–2769. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact